알츠하이머 치매 환자의 약물 순응도에 영향을 미치는 요인
Variables Influencing drug Adherence in Patients with Alzheimer’s Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives：Many patients with Alzheimer’s disease have difficulty in taking their medicine by themselves and their poor drug adherence possibly results in aggravating various symptoms. The aim of this study was to assess the variables influencing drug adherence of Alzheimer’s disease patients. Methods：In a four-week period, 33 outpatients over 65 years old diagnosed with Alzheimer’s disease were monitored. Drug adherences were assessed by the Medication Event Monitoring System (MEMS), the pill count, the clinician rating scale, and self-report. Agreements among adherence measures and the relationships between MEMS adherence and other clinical factors were assessed. Results：The adherence rates for the MEMS, the pill count, the clinician rating scale and, self-report were 51.5%, 82.8%, 82.8%, and 87.9%. The Kappa coefficients were 0.382 (pill count vs. MEMS, clinician rating scale vs. MEMS) and 0.256 (self-report vs. MEMS). Males showed better adherence than females but the other clinical variables did not show significant differences between adherence group and non-adherence group. Conclusion：These findings suggest that clinicians should be concerned when assessing drug adherence in patients with Alzheimer’s disease only by subjective reporting and pill counting since these methods may make patient’s adherence underestimate. Clinicians should also take in mind that caregivers play an important role in improving adherence.
Abstract
Objectives：Many patients with Alzheimer’s disease have difficulty in taking their medicine by themselves and their poor drug adherence possibly results in aggravating various symptoms. The aim of this study was to assess the variables influencing drug adherence of Alzheimer’s disease patients. Methods：In a four-week period, 33 outpatients over 65 years old diagnosed with Alzheimer’s disease were monitored. Drug adherences were assessed by the Medication Event Monitoring System (MEMS), the pill count, the clinician rating scale, and self-report. Agreements among adherence measures and the relationships between MEMS adherence and other clinical factors were assessed. Results：The adherence rates for the MEMS, the pill count, the clinician rating scale and, self-report were 51.5%, 82.8%, 82.8%, and 87.9%. The Kappa coefficients were 0.382 (pill count vs. MEMS, clinician rating scale vs. MEMS) and 0.256 (self-report vs. MEMS). Males showed better adherence than females but the other clinical variables did not show significant differences between adherence group and non-adherence group. Conclusion：These findings suggest that clinicians should be concerned when assessing drug adherence in patients with Alzheimer’s disease only by subjective reporting and pill counting since these methods may make patient’s adherence underestimate. Clinicians should also take in mind that caregivers play an important role in improving adherence.
참고문헌 (30)
- Wallin AK, "Galantamine treatment in Alzheimer’s disease: response and long-term outcome in a routine clinical setting", Neuropsychiatr Dis Treat, 7, pp.565~576 (2011)
- Arlt S, "Adherence to medication in patients with dementia: predictors and strategies for improvement", Drugs Aging, 25, pp.1033~1047 (2008)
- Campbell NL, "Medication adherence in older adults with cognitive impairment: a systematic evidence-based review", Am J Geriatr Pharmacother, 10, pp.165~177 (2012)
- Small G, "A review of compliance to treatment in Alzheimer’s disease: potential benefits of a transdermal patch", Curr Med Res Opin, 23, pp.2705~2713 (2007)
- Thiruchselvam T, "Risk factors for medication nonadherence in older adults with cognitive impairment who live alone", Int J Geriatr Psychiatry, 27, pp.1275~1282 (2012)
- Poon I, "Racial", ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study, 2009, pp.43, 185~193
- Boucher L, "Cognitively impaired spouses as primary caregivers for demented elderly people", J Am Geriatr Soc, 44, pp.828~831 (1996)
- Borah B, "Predictors of Adherence among Alzheimer’s Disease Patients Receiving Oral Therapy: Results of a Retrospective Database Analysis", Neurology, 74, pp.A269~A270 (2010)
- Claxton AJ, "A systematic review of the associations between dose regimens and medication compliance", Clin Ther, 23, pp.1296~1310 (2001)
- Byerly MJ, "Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia", Psychiatr Serv, 58, pp.844~847 (2007)
- Schwalbe O, "Compliance assessment of ambulatory Alzheimer patients to aid therapeutic decisions by healthcare professionals", BMC Health Serv Res, 10, pp.232~ (2010)
- Diaz E, "Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia", J Psychiatry Neurosci, 26, pp.325~329 (2001)
- Bies RR, "Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques", Am J Geriatr Psychiatry, 10, pp.696~705 (2002)
- Kwon YC, "Korean version of Mini-Mental State Examina tion (MMSE-K): part I: development of the test for the elderly", J Korean Neuropsychiatr Assoc, 28, pp.125~135 (1989)
- Tuokko H, "The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease", J Am Geriatr Soc, 40, pp.579~584 (1992)
- Chey JY, "Development of the norms for the Korean-Dementia Rating Scale", Korean J Clin Psychol, 16, pp.423~433 (1997)
- Hughes CP, "A new clinical scale for the staging of dementia", Br J Psychiatry, 140, pp.566~572 (1982)
- Choi SH, "The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients", J Korean Med Sci, 15, pp.609~615 (2000)
- Suh SY, "A study for the development of Korean version of the Duke-UNC functional social support questionnaire", J Korean Acad Fam Med, 18, pp.250~260 (1997)
- Remington G, "The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia", Schizophr Res, 90, pp.229~237 (2007)
- Lee MS, "Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders", J Affect Disord, 123, pp.216~221 (2010)
- Kemp R, "Compliance therapy in psychotic patients: randomised controlled trial", BMJ, 312, pp.345~349 (1996)
- Kemp R, "Randomised controlled trial of compliance therapy. 18-month follow-up", Br J Psychiatry, 172, pp.413~419 (1998)
- Byerly M, "A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia", Psychiatry Res, 133, pp.129~133 (2005)
- Yang J, "Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia", Schizophr Res, 134, pp.226~231 (2012)
- Sadock BJ, "Synopsis of Psychiatry", pp.1351~ (2007), Lippincott Williams & Wilkins
- Lyketsos CG, "Neuropsychiatric symptoms in Alzheimer’s disease", Alzheimers Dement, 7, pp.532~539 (2011)
- Petersen RC, "Aging, memory, and mild cognitive impairment", Int Psychogeriatr, 9(Suppl 1), pp.65~69 (1997)
- Desai AK, "Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment", CNS Drugs, 18, pp.853~875 (2004)
- Choi-Kwon S, "Factors affecting the burden on caregivers of stroke survivors in South Korea", Arch Phys Med Rehabil, 86, pp.1043~1048 (2005)